speb/financial-data huggingface dataset:
XYL income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 6000000.00
XYL balance_sheet (quarterly, 2025-09-30) — Payables: 1123000000.00
XYL balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 1678000000.00
XYL balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 335000000.00
XYL income_statement (quarterly, 2025-09-30) — Pretax Income: 297000000.00
XYL cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 3000000.00
XYL cash_flow (quarterly, 2025-09-30) — Purchase Of Business: -108000000.00
XYL cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -26000000.00
XYL balance_sheet (quarterly, 2025-09-30) — Raw Materials: 553000000.00
XYL balance_sheet (quarterly, 2025-09-30) — Receivables: 1803000000.00
XYL income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 1385000000.00
XYL income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 142000000.00
XYL cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -32000000.00
XYL cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -1000000.00
XYL income_statement (quarterly, 2025-09-30) — Research And Development: 52000000.00
XYL income_statement (quarterly, 2025-09-30) — Restructuring And Mergern Acquisition: 23000000.00
XYL balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 3469000000.00
XYL cash_flow (quarterly, 2025-09-30) — Sale Of Business: -2000000.00
XYL cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 15000000.00
XYL cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 10000000.00
XYL income_statement (quarterly, 2025-09-30) — Selling General And Administration: 474000000.00
XYL balance_sheet (quarterly, 2025-09-30) — Share Issued: 259800000.00
XYL cash_flow (quarterly, 2025-09-30) — Short Term Debt Issuance: -3000000.00
XYL cash_flow (quarterly, 2025-09-30) — Short Term Debt Payments: 0.00
XYL income_statement (quarterly, 2025-09-30) — Special Income Charges: -60000000.00
XYL cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 12000000.00
XYL balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 11207000000.00
XYL balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 608000000.00
XYL income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -14340000.00
XYL income_statement (quarterly, 2025-09-30) — Tax Provision: 71000000.00
XYL income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.24
XYL balance_sheet (quarterly, 2025-09-30) — Total Assets: 17295000000.00
XYL balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 13120000000.00
XYL balance_sheet (quarterly, 2025-09-30) — Total Debt: 2089000000.00
XYL balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 11445000000.00
XYL income_statement (quarterly, 2025-09-30) — Total Expenses: 1911000000.00
XYL balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 5850000000.00
XYL balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 12854000000.00
XYL balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 3581000000.00
XYL income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 334000000.00
XYL balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 155000000.00
XYL income_statement (quarterly, 2025-09-30) — Total Unusual Items: -60000000.00
XYL income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -60000000.00
XYL balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 16300000.00
XYL balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 767000000.00
XYL balance_sheet (quarterly, 2025-09-30) — Work In Process: 115000000.00
XYL balance_sheet (quarterly, 2025-09-30) — Working Capital: 2172000000.00
XYL income_statement (quarterly, 2025-09-30) — Write Off: 0.00
XYL income_statement (annual, 2025-12-31) — +Operating Expense: 2149000000.00
XYL income_statement (quarterly, 2025-12-31) — +Operating Expense: 546000000.00
XYL income_statement (annual, 2025-12-31) — +Total Revenue: 9035000000.00
XYL income_statement (quarterly, 2025-12-31) — +Total Revenue: 2397000000.00
XYL balance_sheet (annual, 2025-12-31) — Accounts Payable: 1013000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 1013000000.00
XYL balance_sheet (annual, 2025-12-31) — Accounts Receivable: 1759000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 1759000000.00
XYL balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -1638000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -1638000000.00
XYL balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 8759000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 8759000000.00
XYL balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -68000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -68000000.00
XYL cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 308000000.00
XYL cash_flow (quarterly, 2025-12-31) — Amortization Cash Flow: 77000000.00
XYL cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 308000000.00
XYL cash_flow (quarterly, 2025-12-31) — Amortization Of Intangibles: 77000000.00
XYL balance_sheet (annual, 2025-12-31) — Assets Held For Sale Current: 176000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Assets Held For Sale Current: 176000000.00
XYL income_statement (annual, 2025-12-31) — Basic Average Shares: 243400000.00
XYL income_statement (annual, 2025-12-31) — Basic EPS: 3.93
XYL cash_flow (annual, 2025-12-31) — Beginning Cash Position: 1121000000.00
XYL cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 1191000000.00
XYL cash_flow (annual, 2025-12-31) — Capital Expenditure: -331000000.00
XYL cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -83000000.00
XYL cash_flow (annual, 2025-12-31) — Capital Expenditure Reported: -331000000.00
XYL cash_flow (quarterly, 2025-12-31) — Capital Expenditure Reported: -83000000.00
XYL balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 121000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 121000000.00
XYL balance_sheet (annual, 2025-12-31) — Capital Stock: 3000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Capital Stock: 3000000.00
XYL balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 1479000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 1479000000.00
XYL balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 1479000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 1479000000.00
XYL cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -391000000.00
XYL cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -98000000.00
XYL cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -501000000.00
XYL cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -119000000.00
XYL cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -471000000.00
XYL cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -142000000.00
XYL cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 1241000000.00
XYL cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 543000000.00
XYL cash_flow (annual, 2025-12-31) — Change In Account Payable: -22000000.00
XYL cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 23000000.00
XYL cash_flow (annual, 2025-12-31) — Change In Accrued Expense: -69000000.00
XYL cash_flow (annual, 2025-12-31) — Change In Inventory: 23000000.00
XYL cash_flow (quarterly, 2025-12-31) — Change In Inventory: 53000000.00
XYL cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -64000000.00
XYL cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 196000000.00
XYL cash_flow (annual, 2025-12-31) — Change In Payable: -22000000.00
XYL cash_flow (quarterly, 2025-12-31) — Change In Payable: 35000000.00
XYL cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -91000000.00
XYL cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -34000000.00
XYL cash_flow (annual, 2025-12-31) — Change In Receivables: -201000000.00
XYL cash_flow (quarterly, 2025-12-31) — Change In Receivables: -88000000.00
XYL cash_flow (annual, 2025-12-31) — Change In Working Capital: -333000000.00
XYL cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 127000000.00
XYL cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -55000000.00
XYL cash_flow (annual, 2025-12-31) — Changes In Cash: 269000000.00
XYL cash_flow (quarterly, 2025-12-31) — Changes In Cash: 282000000.00
XYL balance_sheet (annual, 2025-12-31) — Common Stock: 3000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Common Stock: 3000000.00
XYL cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -391000000.00
XYL cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: -98000000.00
XYL balance_sheet (annual, 2025-12-31) — Common Stock Equity: 11480000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 11480000000.00
XYL cash_flow (annual, 2025-12-31) — Common Stock Payments: -15000000.00
XYL cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -1000000.00
XYL balance_sheet (annual, 2025-12-31) — Construction In Progress: 175000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 175000000.00
XYL income_statement (annual, 2025-12-31) — Cost Of Revenue: 5560000000.00
XYL income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 1465000000.00
XYL balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 538000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 538000000.00
XYL balance_sheet (annual, 2025-12-31) — Current Assets: 4641000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Current Assets: 4641000000.00
XYL balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 121000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 121000000.00
XYL balance_sheet (annual, 2025-12-31) — Current Debt: 534000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Current Debt: 534000000.00
XYL balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 655000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 655000000.00
XYL balance_sheet (annual, 2025-12-31) — Current Liabilities: 2856000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 2856000000.00
XYL cash_flow (annual, 2025-12-31) — Deferred Income Tax: -35000000.00
XYL cash_flow (annual, 2025-12-31) — Deferred Tax: -35000000.00
XYL cash_flow (annual, 2025-12-31) — Depreciation: 267000000.00
XYL cash_flow (quarterly, 2025-12-31) — Depreciation: 66000000.00
XYL cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 575000000.00
XYL cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 143000000.00
XYL cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 575000000.00
XYL cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 143000000.00
XYL income_statement (annual, 2025-12-31) — Diluted Average Shares: 244000000.00
XYL income_statement (annual, 2025-12-31) — Diluted EPS: 3.92
XYL income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 957000000.00
XYL income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 335000000.00
XYL income_statement (annual, 2025-12-31) — EBIT: 1210000000.00
XYL income_statement (quarterly, 2025-12-31) — EBIT: 374000000.00
XYL income_statement (annual, 2025-12-31) — EBITDA: 1785000000.00
XYL income_statement (quarterly, 2025-12-31) — EBITDA: 517000000.00
XYL income_statement (annual, 2025-12-31) — Earnings From Equity Interest: 2000000.00
XYL cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 90000000.00
XYL cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 7000000.00
XYL balance_sheet (annual, 2025-12-31) — Employee Benefits: 317000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Employee Benefits: 317000000.00
XYL cash_flow (annual, 2025-12-31) — End Cash Position: 1479000000.00
XYL cash_flow (quarterly, 2025-12-31) — End Cash Position: 1479000000.00
XYL cash_flow (annual, 2025-12-31) — Financing Cash Flow: -501000000.00
XYL cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -119000000.00
XYL balance_sheet (annual, 2025-12-31) — Finished Goods: 342000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Finished Goods: 342000000.00
XYL cash_flow (annual, 2025-12-31) — Free Cash Flow: 910000000.00
XYL cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 460000000.00
XYL cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of Business: 31000000.00
XYL cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of Business: -16000000.00
XYL income_statement (annual, 2025-12-31) — Gain On Sale Of Business: -31000000.00
XYL income_statement (quarterly, 2025-12-31) — Gain On Sale Of Business: 16000000.00
XYL balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -220000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -220000000.00
XYL income_statement (annual, 2025-12-31) — General And Administrative Expense: 1923000000.00
XYL balance_sheet (annual, 2025-12-31) — Goodwill: 8332000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Goodwill: 8332000000.00
XYL balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 10604000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 10604000000.00
XYL balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 1827000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 1827000000.00
XYL balance_sheet (annual, 2025-12-31) — Gross PPE: 2797000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Gross PPE: 2797000000.00
XYL income_statement (annual, 2025-12-31) — Gross Profit: 3475000000.00
XYL income_statement (quarterly, 2025-12-31) — Gross Profit: 932000000.00
XYL cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 267000000.00
XYL cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 59000000.00
XYL income_statement (annual, 2025-12-31) — Interest Expense: 29000000.00
XYL income_statement (quarterly, 2025-12-31) — Interest Expense: 6000000.00
XYL income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 29000000.00
XYL income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 6000000.00
XYL income_statement (annual, 2025-12-31) — Interest Income: 27000000.00
XYL income_statement (annual, 2025-12-31) — Interest Income Non Operating: 27000000.00
XYL cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 61000000.00
XYL cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 18000000.00
XYL balance_sheet (annual, 2025-12-31) — Inventory: 983000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Inventory: 983000000.00
XYL balance_sheet (annual, 2025-12-31) — Invested Capital: 13422000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Invested Capital: 13422000000.00
XYL cash_flow (annual, 2025-12-31) — Investing Cash Flow: -471000000.00
XYL cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -142000000.00
XYL cash_flow (annual, 2025-12-31) — Issuance Of Debt: 1000000.00
XYL cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 0.00
XYL balance_sheet (annual, 2025-12-31) — Long Term Debt: 1408000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 1408000000.00
XYL balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 1408000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 1408000000.00
XYL cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 0.00
XYL cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -82000000.00
XYL cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -22000000.00
XYL balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 1691000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 1691000000.00
XYL balance_sheet (annual, 2025-12-31) — Minority Interest: 269000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Minority Interest: 269000000.00
XYL income_statement (annual, 2025-12-31) — Minority Interests: 7000000.00
XYL income_statement (quarterly, 2025-12-31) — Minority Interests: 2000000.00
XYL cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: -114000000.00
XYL cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: -44000000.00
XYL cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -15000000.00
XYL cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -1000000.00
XYL balance_sheet (annual, 2025-12-31) — Net Debt: 463000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Net Debt: 463000000.00
XYL income_statement (annual, 2025-12-31) — Net Income: 957000000.00
XYL income_statement (quarterly, 2025-12-31) — Net Income: 335000000.00
XYL income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 957000000.00
XYL income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 335000000.00
XYL income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 950000000.00
XYL income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 333000000.00
XYL income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 957000000.00
XYL income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 335000000.00
XYL income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 957000000.00
XYL income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 335000000.00
XYL cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 950000000.00
XYL cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 333000000.00
XYL income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 950000000.00
XYL income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 333000000.00
XYL income_statement (annual, 2025-12-31) — Net Interest Income: -2000000.00
XYL income_statement (quarterly, 2025-12-31) — Net Interest Income: 21000000.00
XYL cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -6000000.00
XYL cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -16000000.00
XYL cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -81000000.00
XYL cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -22000000.00
XYL cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -82000000.00
XYL cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -22000000.00
XYL income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -2000000.00
XYL income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 21000000.00
XYL cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -34000000.00
XYL cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -7000000.00
XYL cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -37000000.00
XYL cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: -1000000.00
XYL balance_sheet (annual, 2025-12-31) — Net PPE: 1159000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Net PPE: 1159000000.00
XYL cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: 17000000.00
XYL cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: 2000000.00
XYL cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: 1000000.00
XYL cash_flow (quarterly, 2025-12-31) — Net Short Term Debt Issuance: 0.00
XYL balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 876000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 876000000.00
XYL balance_sheet (annual, 2025-12-31) — Non Current Accrued Expenses: 899000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Non Current Accrued Expenses: 899000000.00
XYL balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 405000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 405000000.00
XYL balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 405000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 405000000.00
XYL balance_sheet (annual, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 317000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 317000000.00
XYL income_statement (annual, 2025-12-31) — Normalized EBITDA: 1919000000.00
XYL income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 534000000.00
XYL income_statement (annual, 2025-12-31) — Normalized Income: 1064870000.00
XYL income_statement (quarterly, 2025-12-31) — Normalized Income: 350383152.17
XYL cash_flow (annual, 2025-12-31) — Operating Cash Flow: 1241000000.00
XYL cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 543000000.00
XYL cash_flow (annual, 2025-12-31) — Operating Gains Losses: 31000000.00
XYL cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -16000000.00
XYL income_statement (annual, 2025-12-31) — Operating Income: 1326000000.00
XYL income_statement (quarterly, 2025-12-31) — Operating Income: 386000000.00
XYL income_statement (annual, 2025-12-31) — Operating Revenue: 9035000000.00
XYL income_statement (quarterly, 2025-12-31) — Operating Revenue: 2397000000.00
XYL balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 243584000.00
XYL balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 243584000.00
XYL cash_flow (annual, 2025-12-31) — Other Cash Adjustment Outside Changein Cash: -1000000.00
XYL balance_sheet (annual, 2025-12-31) — Other Current Assets: 244000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 244000000.00
XYL balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 534000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 534000000.00
XYL balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 72000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 72000000.00
XYL balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -220000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -220000000.00
XYL income_statement (annual, 2025-12-31) — Other Gand A: 1923000000.00
XYL income_statement (annual, 2025-12-31) — Other Income Expense: -143000000.00
XYL income_statement (quarterly, 2025-12-31) — Other Income Expense: -39000000.00
XYL balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 2272000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 2272000000.00
XYL balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 1230000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 1230000000.00
XYL income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: -11000000.00
XYL income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: -24000000.00
XYL balance_sheet (annual, 2025-12-31) — Other Properties: 419000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Other Properties: 419000000.00
XYL balance_sheet (annual, 2025-12-31) — Payables: 1220000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Payables: 1220000000.00
XYL balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 1758000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 1758000000.00
XYL balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 371000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 371000000.00
XYL income_statement (annual, 2025-12-31) — Pretax Income: 1181000000.00
XYL income_statement (quarterly, 2025-12-31) — Pretax Income: 368000000.00
XYL cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 20000000.00
XYL cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 9000000.00
XYL balance_sheet (annual, 2025-12-31) — Properties: 512000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Properties: 512000000.00
XYL cash_flow (annual, 2025-12-31) — Purchase Of Business: -163000000.00
XYL cash_flow (quarterly, 2025-12-31) — Purchase Of Business: -45000000.00
XYL cash_flow (annual, 2025-12-31) — Purchase Of Investment: -49000000.00
XYL cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -23000000.00
XYL balance_sheet (annual, 2025-12-31) — Raw Materials: 541000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Raw Materials: 541000000.00
XYL balance_sheet (annual, 2025-12-31) — Receivables: 1759000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Receivables: 1759000000.00
XYL income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 5560000000.00
XYL income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 1465000000.00
XYL income_statement (annual, 2025-12-31) — Reconciled Depreciation: 575000000.00
XYL income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 143000000.00
XYL cash_flow (annual, 2025-12-31) — Repayment Of Debt: -82000000.00
XYL cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -22000000.00
XYL cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -15000000.00
XYL cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -1000000.00
XYL income_statement (annual, 2025-12-31) — Research And Development: 226000000.00
XYL income_statement (quarterly, 2025-12-31) — Research And Development: 60000000.00
XYL income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: 95000000.00
XYL income_statement (quarterly, 2025-12-31) — Restructuring And Mergern Acquisition: 33000000.00
XYL balance_sheet (annual, 2025-12-31) — Retained Earnings: 3706000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 3706000000.00
XYL cash_flow (annual, 2025-12-31) — Sale Of Business: 49000000.00
XYL cash_flow (quarterly, 2025-12-31) — Sale Of Business: 1000000.00
XYL cash_flow (annual, 2025-12-31) — Sale Of Investment: 43000000.00
XYL cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 7000000.00
XYL cash_flow (annual, 2025-12-31) — Sale Of PPE: 17000000.00
XYL cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 2000000.00
XYL income_statement (annual, 2025-12-31) — Selling General And Administration: 1923000000.00
XYL income_statement (quarterly, 2025-12-31) — Selling General And Administration: 486000000.00
XYL balance_sheet (annual, 2025-12-31) — Share Issued: 259884000.00
XYL balance_sheet (quarterly, 2025-12-31) — Share Issued: 259884000.00
XYL cash_flow (annual, 2025-12-31) — Short Term Debt Issuance: 1000000.00
XYL cash_flow (quarterly, 2025-12-31) — Short Term Debt Issuance: 0.00
XYL cash_flow (annual, 2025-12-31) — Short Term Debt Payments: 0.00
XYL cash_flow (quarterly, 2025-12-31) — Short Term Debt Payments: 0.00
XYL income_statement (annual, 2025-12-31) — Special Income Charges: -134000000.00
XYL income_statement (quarterly, 2025-12-31) — Special Income Charges: -17000000.00
XYL cash_flow (annual, 2025-12-31) — Stock Based Compensation: 53000000.00
XYL cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 16000000.00
XYL balance_sheet (annual, 2025-12-31) — Stockholders Equity: 11480000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 11480000000.00
XYL balance_sheet (annual, 2025-12-31) — Tangible Book Value: 876000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 876000000.00
XYL income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -26130000.00
XYL income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -1616847.83
XYL income_statement (annual, 2025-12-31) — Tax Provision: 231000000.00
XYL income_statement (quarterly, 2025-12-31) — Tax Provision: 35000000.00
XYL income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.20
XYL income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.10
XYL balance_sheet (annual, 2025-12-31) — Total Assets: 17634000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Total Assets: 17634000000.00
XYL balance_sheet (annual, 2025-12-31) — Total Capitalization: 12888000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 12888000000.00
XYL balance_sheet (annual, 2025-12-31) — Total Debt: 2063000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Total Debt: 2063000000.00
XYL balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 11749000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 11749000000.00
XYL income_statement (annual, 2025-12-31) — Total Expenses: 7709000000.00
XYL income_statement (quarterly, 2025-12-31) — Total Expenses: 2011000000.00
XYL balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 5885000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 5885000000.00
XYL balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 12993000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 12993000000.00
XYL balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 3029000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 3029000000.00
XYL income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 1223000000.00
XYL income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 353000000.00
XYL balance_sheet (annual, 2025-12-31) — Total Tax Payable: 207000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 207000000.00
XYL income_statement (annual, 2025-12-31) — Total Unusual Items: -134000000.00
XYL income_statement (quarterly, 2025-12-31) — Total Unusual Items: -17000000.00
XYL income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -134000000.00
XYL income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -17000000.00
XYL balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 16300000.00
XYL balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 16300000.00
XYL balance_sheet (annual, 2025-12-31) — Treasury Stock: 768000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 768000000.00
XYL cash_flow (annual, 2025-12-31) — Unrealized Gain Loss On Investment Securities: 0.00
XYL balance_sheet (annual, 2025-12-31) — Work In Process: 100000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Work In Process: 100000000.00
XYL balance_sheet (annual, 2025-12-31) — Working Capital: 1785000000.00
XYL balance_sheet (quarterly, 2025-12-31) — Working Capital: 1785000000.00
XYL income_statement (annual, 2025-12-31) — Write Off: 8000000.00
XYL income_statement (quarterly, 2025-12-31) — Write Off: 0.00
XYL income_statement (quarterly, 2026-03-31) — +Operating Expense: 528000000.00
XYL income_statement (quarterly, 2026-03-31) — +Total Revenue: 2125000000.00
XYL balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 969000000.00
XYL balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 1796000000.00
XYL balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 8772000000.00
XYL balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -53000000.00
XYL cash_flow (quarterly, 2026-03-31) — Amortization Cash Flow: 75000000.00
XYL cash_flow (quarterly, 2026-03-31) — Amortization Of Intangibles: 75000000.00
XYL balance_sheet (quarterly, 2026-03-31) — Assets Held For Sale Current: 192000000.00
XYL income_statement (quarterly, 2026-03-31) — Basic Average Shares: 242800000.00
XYL income_statement (quarterly, 2026-03-31) — Basic EPS: 0.79
XYL cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 1479000000.00
XYL cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -90000000.00
XYL cash_flow (quarterly, 2026-03-31) — Capital Expenditure Reported: -90000000.00
XYL balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 123000000.00
XYL balance_sheet (quarterly, 2026-03-31) — Capital Stock: 3000000.00
XYL balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 808000000.00
XYL balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 808000000.00
XYL cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -106000000.00
XYL cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -683000000.00
XYL cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -76000000.00
XYL cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 108000000.00
XYL cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -61000000.00
XYL cash_flow (quarterly, 2026-03-31) — Change In Inventory: -18000000.00
XYL cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: -48000000.00
XYL cash_flow (quarterly, 2026-03-31) — Change In Payable: -61000000.00
XYL cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -61000000.00
XYL cash_flow (quarterly, 2026-03-31) — Change In Receivables: -89000000.00
XYL cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -216000000.00
XYL cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -58000000.00
XYL cash_flow (quarterly, 2026-03-31) — Changes In Cash: -651000000.00
XYL balance_sheet (quarterly, 2026-03-31) — Common Stock: 3000000.00
XYL cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -106000000.00
XYL balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 10972000000.00
XYL cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -563000000.00
XYL income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 1322000000.00
XYL balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 550000000.00
XYL balance_sheet (quarterly, 2026-03-31) — Current Assets: 4030000000.00
XYL balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 123000000.00
XYL balance_sheet (quarterly, 2026-03-31) — Current Debt: 531000000.00
XYL balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 654000000.00
XYL balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 2755000000.00
XYL cash_flow (quarterly, 2026-03-31) — Depreciation: 65000000.00
XYL cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 140000000.00
XYL cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 140000000.00
XYL income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 243400000.00
XYL income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.79
XYL income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 193000000.00
XYL income_statement (quarterly, 2026-03-31) — EBIT: 248000000.00
XYL income_statement (quarterly, 2026-03-31) — EBITDA: 388000000.00
XYL cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -15000000.00
XYL balance_sheet (quarterly, 2026-03-31) — Employee Benefits: 308000000.00
XYL cash_flow (quarterly, 2026-03-31) — End Cash Position: 808000000.00
XYL cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -683000000.00
XYL balance_sheet (quarterly, 2026-03-31) — Finished Goods: 342000000.00
XYL cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 18000000.00
XYL cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of Business: -4000000.00
XYL income_statement (quarterly, 2026-03-31) — Gain On Sale Of Business: 4000000.00
XYL balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -229000000.00
XYL income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 472000000.00
XYL balance_sheet (quarterly, 2026-03-31) — Goodwill: 8292000000.00
XYL balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 10505000000.00
XYL balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 1849000000.00
XYL income_statement (quarterly, 2026-03-31) — Gross Profit: 803000000.00
XYL cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 28000000.00
XYL income_statement (quarterly, 2026-03-31) — Interest Expense: 4000000.00
XYL income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 4000000.00
XYL cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 11000000.00
XYL balance_sheet (quarterly, 2026-03-31) — Inventory: 991000000.00
XYL balance_sheet (quarterly, 2026-03-31) — Invested Capital: 12910000000.00
XYL cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -76000000.00
XYL cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 0.00
XYL balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 1407000000.00
XYL balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 1407000000.00
XYL cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -4000000.00
XYL balance_sheet (quarterly, 2026-03-31) — Minority Interest: 257000000.00
XYL income_statement (quarterly, 2026-03-31) — Minority Interests: 4000000.00
XYL cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: 0.00
XYL cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -563000000.00
XYL balance_sheet (quarterly, 2026-03-31) — Net Debt: 1130000000.00
XYL income_statement (quarterly, 2026-03-31) — Net Income: 193000000.00
XYL income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 193000000.00
XYL income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 189000000.00
XYL income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 193000000.00
XYL income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 193000000.00
XYL cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 189000000.00
XYL income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 189000000.00
XYL income_statement (quarterly, 2026-03-31) — Net Interest Income: -4000000.00
XYL cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 14000000.00
XYL cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -4000000.00
XYL cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -4000000.00
XYL income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -4000000.00
XYL cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -10000000.00
XYL cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: -1000000.00
XYL balance_sheet (quarterly, 2026-03-31) — Net PPE: 1151000000.00
XYL cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: 1000000.00
XYL cash_flow (quarterly, 2026-03-31) — Net Short Term Debt Issuance: 0.00
XYL balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 467000000.00
XYL balance_sheet (quarterly, 2026-03-31) — Non Current Accrued Expenses: 818000000.00
XYL balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 437000000.00
XYL balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 437000000.00
XYL balance_sheet (quarterly, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 308000000.00
XYL income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 415000000.00
XYL income_statement (quarterly, 2026-03-31) — Normalized Income: 213979000.00
XYL cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 108000000.00
XYL cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -4000000.00
XYL income_statement (quarterly, 2026-03-31) — Operating Income: 275000000.00
XYL income_statement (quarterly, 2026-03-31) — Operating Revenue: 2125000000.00
XYL balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 239100000.00
XYL cash_flow (quarterly, 2026-03-31) — Other Cash Adjustment Outside Changein Cash: -5000000.00
XYL balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 243000000.00
XYL balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 531000000.00
XYL balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 73000000.00
XYL balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -229000000.00
XYL income_statement (quarterly, 2026-03-31) — Other Gand A: 472000000.00
XYL income_statement (quarterly, 2026-03-31) — Other Income Expense: -27000000.00
XYL balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 2213000000.00
XYL cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -14000000.00
XYL balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 1268000000.00
XYL balance_sheet (quarterly, 2026-03-31) — Payables: 1200000000.00
XYL balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 1750000000.00
XYL balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 278000000.00
XYL income_statement (quarterly, 2026-03-31) — Pretax Income: 244000000.00
XYL cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 0.00
XYL cash_flow (quarterly, 2026-03-31) — Purchase Of Business: 0.00
XYL cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: 0.00
XYL balance_sheet (quarterly, 2026-03-31) — Raw Materials: 540000000.00
XYL balance_sheet (quarterly, 2026-03-31) — Receivables: 1796000000.00
XYL income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 1322000000.00
XYL income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 140000000.00
XYL cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -4000000.00
XYL cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -563000000.00
XYL income_statement (quarterly, 2026-03-31) — Research And Development: 56000000.00
XYL income_statement (quarterly, 2026-03-31) — Restructuring And Mergern Acquisition: 30000000.00
XYL balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 3794000000.00
XYL cash_flow (quarterly, 2026-03-31) — Sale Of Business: 0.00
XYL cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 14000000.00
XYL cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 1000000.00
XYL income_statement (quarterly, 2026-03-31) — Selling General And Administration: 472000000.00
XYL balance_sheet (quarterly, 2026-03-31) — Share Issued: 260300000.00
XYL cash_flow (quarterly, 2026-03-31) — Short Term Debt Issuance: 0.00
XYL income_statement (quarterly, 2026-03-31) — Special Income Charges: -27000000.00
XYL cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 13000000.00
XYL balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 10972000000.00
XYL balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 467000000.00
XYL income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -6021000.00
XYL income_statement (quarterly, 2026-03-31) — Tax Provision: 55000000.00
XYL income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.22
XYL balance_sheet (quarterly, 2026-03-31) — Total Assets: 16954000000.00
XYL balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 12379000000.00
XYL balance_sheet (quarterly, 2026-03-31) — Total Debt: 2061000000.00
XYL balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 11229000000.00
XYL income_statement (quarterly, 2026-03-31) — Total Expenses: 1850000000.00
XYL balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 5725000000.00
XYL balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 12924000000.00
XYL balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 2970000000.00
XYL income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 244000000.00
XYL balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 231000000.00
XYL income_statement (quarterly, 2026-03-31) — Total Unusual Items: -27000000.00
XYL income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -27000000.00
XYL balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 21200000.00
XYL balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 1368000000.00
XYL balance_sheet (quarterly, 2026-03-31) — Work In Process: 109000000.00
XYL balance_sheet (quarterly, 2026-03-31) — Working Capital: 1275000000.00
XYL income_statement (quarterly, 2026-03-31) — Write Off: 1000000.00
XYZ cash_flow (annual, 2021-12-31) — Gain Loss On Investment Securities: -35492000.00
XYZ cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of Business: 0.00
XYZ income_statement (annual, 2021-12-31) — Gain On Sale Of Ppe: 0.00
XYZ income_statement (annual, 2021-12-31) — Interest Expense: 33124000.00
XYZ income_statement (annual, 2021-12-31) — Interest Expense Non Operating: 33124000.00
XYZ balance_sheet (annual, 2021-12-31) — Line Of Credit: 497533000.00
XYZ cash_flow (annual, 2021-12-31) — Net Business Purchase And Sale: -163970000.00
XYZ balance_sheet (annual, 2021-12-31) — Net Debt: 613527000.00
XYZ cash_flow (annual, 2021-12-31) — Net Intangibles Purchase And Sale: -170000000.00
XYZ cash_flow (annual, 2021-12-31) — Net Short Term Debt Issuance: 33439000.00
XYZ income_statement (annual, 2021-12-31) — Other Operating Expenses: 187991000.00
XYZ cash_flow (annual, 2021-12-31) — Purchase Of Business: -163970000.00
XYZ cash_flow (annual, 2021-12-31) — Purchase Of Intangibles: -170000000.00
XYZ cash_flow (annual, 2021-12-31) — Sale Of Business: 0.00
XYZ cash_flow (annual, 2021-12-31) — Short Term Debt Issuance: 681539000.00
XYZ cash_flow (annual, 2021-12-31) — Short Term Debt Payments: -648100000.00
XYZ cash_flow (annual, 2021-12-31) — Unrealized Gain Loss On Investment Securities: 0.00
XYZ income_statement (annual, 2021-12-31) — Write Off: 71126000.00
XYZ income_statement (annual, 2022-12-31) — +Operating Expense: 6019170000.00
XYZ income_statement (annual, 2022-12-31) — +Total Revenue: 17531587000.00
XYZ balance_sheet (annual, 2022-12-31) — Accounts Payable: 558351000.00
XYZ balance_sheet (annual, 2022-12-31) — Accounts Receivable: 4427992000.00
XYZ balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -367547000.00
XYZ balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 18314681000.00
XYZ balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -151290000.00
XYZ income_statement (annual, 2022-12-31) — Amortization: 138758000.00
XYZ income_statement (annual, 2022-12-31) — Amortization Of Intangibles Income Statement: 138758000.00
XYZ cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 46571000.00
XYZ balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 208880000.00
XYZ income_statement (annual, 2022-12-31) — Basic Average Shares: 578949000.00
XYZ income_statement (annual, 2022-12-31) — Basic EPS: -0.93
XYZ cash_flow (annual, 2022-12-31) — Beginning Cash Position: 6975090000.00
XYZ cash_flow (annual, 2022-12-31) — Capital Expenditure: -170815000.00
XYZ balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 424273000.00
XYZ balance_sheet (annual, 2022-12-31) — Capital Stock: 0.00
XYZ balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 7724526000.00
XYZ balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 8806377000.00
XYZ balance_sheet (annual, 2022-12-31) — Cash Equivalents: 1431341000.00
XYZ balance_sheet (annual, 2022-12-31) — Cash Financial: 6293185000.00
XYZ cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 97580000.00
XYZ cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: 1225696000.00
XYZ cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 175903000.00
XYZ cash_flow (annual, 2022-12-31) — Change In Account Payable: 1268755000.00
XYZ cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -369639000.00
XYZ cash_flow (annual, 2022-12-31) — Change In Payable: 1268755000.00
XYZ cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 1268755000.00
XYZ cash_flow (annual, 2022-12-31) — Change In Receivables: -1499057000.00
XYZ cash_flow (annual, 2022-12-31) — Change In Working Capital: -599941000.00
XYZ cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -1499057000.00